Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-18

FDA Approved: ATORVASTATIN CALCIUM — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma's generic atorvastatin calcium (original ANDA) for lowering cholesterol and reducing cardiovascular risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atorvastatin calcium (generic) (atorvastatin calcium)

Snippet

ORIG AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM, FILM COATED)